Occupational Therapist-Led Work Intervention in Facilitating Work Maintenance or Re-entry to the Workforce in Patients With Stage I to III Breast Cancer Undergoing Chemotherapy

Breast Cancer Clinical Trial

Official title:

The Evaluation of a Work Intervention to Facilitate Work Maintenance or Re-Entry to the Workforce for Breast Cancer Patients

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT03723863
• Other study ID #: RG1718049
• Secondary ID: NCI-2018-0205999
• Status: Terminated
• Phase: N/A
• Start date: October 25, 2018
• Est. completion date: September 22, 2020

Study information

• Verified date: June 2021
• Source: University of Washington
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This trial studies how well occupational therapy (occupational therapist-led work intervention) works in facilitating work maintenance or re-entry to the workforce for stages I to III breast cancer patients who will be undergoing curative intent chemotherapy. Occupational therapy may help cancer patients maintain employment or successfully return to work soon after treatment.

Description:

Patients receive in-person occupational therapist-led work consultation.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 15
• Est. completion date: September 22, 2020
• Est. primary completion date: September 22, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Stage I-III breast cancer patients who will be undergoing curative intent chemotherapy

• Working in a paid capacity (part or full-time) at time of diagnosis with the intent to maintain or return to work following treatment

Exclusion Criteria:

• Non-English speaking patients. This study requires completing online questionnaires that are written in English and will not be translated

• Patients with a psychiatric or neurological condition that impairs capacity to make decisions

Related Conditions & MeSH terms

• Breast Cancer
• Breast Cancer Stage I
• Breast Cancer Stage II
• Breast Cancer Stage IIA
• Breast Cancer Stage IIB
• Breast Cancer Stage III
• Breast Cancer Stage IIIA
• Breast Cancer Stage IIIB
• Breast Cancer Stage IIIc
• Breast Neoplasms

Intervention

Behavioral:
• Occupational Therapy
Receive in-person occupational therapist-led work consultation

Locations

Country	Name	City	State
United States	Fred Hutch/University of Washington Cancer Consortium	Seattle	Washington

Sponsors (1)

Lead Sponsor	Collaborator
University of Washington

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in perceived work ability	Will be measured by the Work Abilities Index (WAI).	Baseline up to 3 years
Secondary	Change in health related quality of life	Will be measured by the Functional Assessment of Cancer Therapy General (FACT-G), a validated measure for quality of life in patients with cancer.	Baseline up to 3 years
Secondary	Change in financial toxicity	Will be measured by the Comprehensive Score for Financial Toxicity (COST-FACIT), a validated measure for financial toxicity for clinically relevant patient-centered outcomes.	Baseline up to 3 years